109960 — AP Healthcare Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩70bn
- KR₩73bn
- KR₩16bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 45,996 | 31,705 | 56,393 | 91,274 | 10,223 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 18,870 | 67,756 | 55,011 | 14,211 | 7,377 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 66,036 | 100,896 | 112,238 | 107,988 | 20,232 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 431 | 385 | 155 | 4,365 | 4,336 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 218,361 | 236,889 | 226,742 | 213,393 | 316,557 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6,752 | 3,565 | 3,115 | 12,005 | 27,310 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 7,865 | 5,059 | 4,126 | 14,507 | 29,258 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 210,496 | 231,830 | 222,616 | 198,886 | 287,299 |
Total Liabilities & Shareholders' Equity | 218,361 | 236,889 | 226,742 | 213,393 | 316,557 |
Total Common Shares Outstanding |